{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:18:29Z","timestamp":1761920309943,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T00:00:00Z","timestamp":1497484800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s40291-017-0288-6","type":"journal-article","created":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T08:57:32Z","timestamp":1497517052000},"page":"539-545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Identification and Characterization of a New BRCA2 Rearrangement in an Italian Family with Hereditary Breast and Ovarian Cancer Syndrome"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3472-8898","authenticated-orcid":false,"given":"Paola","family":"Concolino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Rizza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Hackmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Minucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni Luca","family":"Scaglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"De Bonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Costella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Zuppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelin","family":"Schrock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ettore","family":"Capoluongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,15]]},"reference":[{"key":"288_CR1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2016.03.007","volume":"141","author":"LM Randall","year":"2016","unstructured":"Randall LM, Pothuri B. The genetic prediction of risk for gynecologic cancers. Gynecol Oncol. 2016;141:10\u20136.","journal-title":"Gynecol Oncol"},{"key":"288_CR2","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrj\u00e4koski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72:1117\u201330.","journal-title":"Am J Hum Genet"},{"key":"288_CR3","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","volume":"105","author":"N Mavaddat","year":"2013","unstructured":"Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, Evans DG, Izatt L, Eeles RA, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Brewer C, Tischkowitz M, Douglas F, Hodgson S, Walker L, Porteous ME, Morrison PJ, Side LE, Kennedy MJ, Houghton C, Donaldson A, Rogers MT, Dorkins H, Miedzybrodzka Z, Gregory H, Eason J, Barwell J, McCann E, Murray A, Antoniou AC, Easton DF, EMBRACE. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst. 2013;105:812\u201322.","journal-title":"J Natl Cancer Inst"},{"key":"288_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-2350-12-134","volume":"12","author":"Z Garcia-Casado","year":"2011","unstructured":"Garcia-Casado Z, Romero I, Fernandez-Serra A, Rubio L, Llopis F, Garcia A, Llombart P, Lopez-Guerrero J. A de novo complete BRCA1 gene deletion identified in a Spanish woman with early bilateral breast cancer. BMC Med Genet 2011;12:134. doi:\n                        10.1186\/1471-2350-12-134\n                        \n                    .","journal-title":"BMC Med Genet"},{"key":"288_CR5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10549-010-0817-z","volume":"125","author":"MD Sluiter","year":"2011","unstructured":"Sluiter MD, van Rensburg EJ. Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation. Breast Cancer Res Treat. 2011;125:325\u201349.","journal-title":"Breast Cancer Res Treat"},{"key":"288_CR6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cancergencyto.2005.07.005","volume":"168","author":"S Preisler-Adams","year":"2006","unstructured":"Preisler-Adams S, Sch\u00f6nbuchner I, Fiebig B, Welling B, Dworniczak B, Weber BH. Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin. Cancer Genet Cytogenet. 2006;168:44\u20139.","journal-title":"Cancer Genet Cytogenet"},{"key":"288_CR7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1590\/S1415-47572009005000049","volume":"32","author":"IP Ewald","year":"2009","unstructured":"Ewald IP, Ribeiro PL, Palmero EI, Cossio SL, Giugliani R, Ashton-Prolla P. Genomic rearrangements in BRCA1 and BRCA2: a literature review. Genet Mol Biol. 2009;32:437\u201346.","journal-title":"Genet Mol Biol."},{"key":"288_CR8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1086\/339434","volume":"70","author":"N Puget","year":"2002","unstructured":"Puget N, Gad S, Perrin-Vidoz L, Sinilnikova OM, Stoppa-Lyonnet D, Lenoir GM, Mazoyer S. Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot. Am J Hum Genet. 2002;70:858\u201365.","journal-title":"Am J Hum Genet"},{"key":"288_CR9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1101\/gr.6.11.1029","volume":"6","author":"TM Smith","year":"1996","unstructured":"Smith TM, Lee MK, Szabo CI, Jerome N, McEuen M, Taylor M, Hood L, King MC. Complete genomic sequence and analysis of 117\u00a0kb of human DNA containing the gene BRCA1. Genome Res. 1996;6:1029\u201349.","journal-title":"Genome Res"},{"key":"288_CR10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/humu.23137","volume":"38","author":"RD Weren","year":"2017","unstructured":"Weren RD, Mensenkamp AR, Simons M, Eijkelenboom A, Sie AS, Ouchene H, van Asseldonk M, Gomez-Garcia EB, Blok MJ, de Hullu JA, Nelen MR, Hoischen A, Bulten J, Tops BB, Hoogerbrugge N, Ligtenberg MJ. Novel BRCA1 and BRCA2 tumor test as basis for treatment decisions and referral for genetic counselling of patients with ovarian carcinomas. Hum Mutat. 2017;38:226\u201335.","journal-title":"Hum Mutat"},{"key":"288_CR11","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ejhg.2012.270","volume":"21","author":"L Feliubadal\u00f3","year":"2013","unstructured":"Feliubadal\u00f3 L, Lopez-Doriga A, Castellsagu\u00e9 E, del Valle J, Men\u00e9ndez M, Tornero E, Montes E, Cuesta R, G\u00f3mez C, Campos O, Pineda M, Gonz\u00e1lez S, Moreno V, Brunet J, Blanco I, Serra E, Capell\u00e1 G, L\u00e1zaro C. Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes. Eur J Hum Genet. 2013;21:864\u201370.","journal-title":"Eur J Hum Genet"},{"key":"288_CR12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cca.2015.03.045","volume":"446","author":"V D\u2019Argenio","year":"2015","unstructured":"D\u2019Argenio V, Esposito MV, Telese A, Precone V, Starnone F, Nunziato M, Cantiello P, Iorio M, Evangelista E, D\u2019Aiuto M, Calabrese A, Frisso G, D\u2019Aiuto G, Salvatore F. The molecular analysis of BRCA1 and BRCA2: next-generation sequencing supersedes conventional approaches. Clin Chim Acta. 2015;446:221\u20135.","journal-title":"Clin Chim Acta"},{"key":"288_CR13","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1586\/14737159.2015.1081059","volume":"15","author":"A Minucci","year":"2015","unstructured":"Minucci A, Scambia G, Santonocito C, Concolino P, Canu G, Mignone F, Saggese I, Guarino D, Costella A, Molinario R, De Bonis M, Ferrandina G, Petrillo M, Scaglione GL, Capoluongo E. Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: the experience at Gemelli hospital and a literature review. Expert Rev Mol Diagn. 2015;15:1383\u2013403.","journal-title":"Expert Rev Mol Diagn."},{"key":"288_CR14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cca.2014.06.026","volume":"437","author":"P Concolino","year":"2014","unstructured":"Concolino P, Costella A, Minucci A, Scaglione GL, Santonocito C, Salutari V, Scambia G, Zuppi C, Capoluongo E. A preliminary quality control (QC) for next generation sequencing (NGS) library evaluation turns out to be a very useful tool for a rapid detection of BRCA1\/2 deleterious mutations. Clin Chim Acta. 2014;437:72\u20137.","journal-title":"Clin Chim Acta"},{"key":"288_CR15","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cancergen.2015.05.031","volume":"208","author":"A Kwong","year":"2015","unstructured":"Kwong A, Chen J, Shin VY, Ho JC, Law FB, Au CH, Chan TL, Ma ES, Ford JM. The importance of analysis of long-range rearrangement of BRCA1 and BRCA2 in genetic diagnosis of familial breast cancer. Cancer Genet. 2015;208:448\u201354.","journal-title":"Cancer Genet."},{"key":"288_CR16","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1515\/cclm-2013-1114","volume":"52","author":"P Concolino","year":"2014","unstructured":"Concolino P, Mello E, Minucci A, Santonocito C, Scambia G, Giardina B, Capoluongo E. Advanced tools for BRCA1\/2 mutational screening: comparison between two methods for large genomic rearrangements (LGRs) detection. Clin Chem Lab Med. 2014;52:1119\u201327.","journal-title":"Clin Chem Lab Med"},{"key":"288_CR17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10549-016-3956-z","volume":"159","author":"K Hackmann","year":"2016","unstructured":"Hackmann K, Kuhlee F, Betcheva-Krajcir E, Kahlert AK, Mackenroth L, Klink B, Di Donato N, Tzschach A, Kast K, Wimberger P, Schrock E, Rump A. Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH. Breast Cancer Res Treat. 2016;159:585\u201390.","journal-title":"Breast Cancer Res Treat"},{"key":"288_CR18","unstructured":"RepeatMasker Open-3.0 website. \n                        http:\/\/www.repeatmasker.org\n                        \n                    . Accessed 6 Mar 2014."},{"key":"288_CR19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/humu.22938","volume":"37","author":"MJ Smith","year":"2016","unstructured":"Smith MJ, Urquhart JE, Harkness EF, Miles EK, Bowers NL, Byers HJ, Bulman M, Gokhale C, Wallace AJ, Newman WG, Evans DG. The contribution of whole gene deletions and large rearrangements to the mutation spectrum in inherited tumor predisposing syndromes. Hum Mutat. 2016;37:250\u20136.","journal-title":"Hum Mutat"},{"key":"288_CR20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10549-011-1909-0","volume":"133","author":"GR Garibay de","year":"2012","unstructured":"de Garibay GR, Guti\u00e9rrez-Enr\u00edquez S, Garre P, Bonache S, Romero A, Palomo L, S\u00e1nchez de Abajo A, Ben\u00edtez J, Balma\u00f1a J, P\u00e9rez-Segura P, D\u00edaz-Rubio E, D\u00edez O, Cald\u00e9s T, de la Hoya M. Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast\/ovarian cancer families: review of the literature, and reevaluation of the genetic mechanisms involved in their origin. Breast Cancer Res Treat. 2012;133:273\u201383.","journal-title":"Breast Cancer Res Treat."},{"key":"288_CR21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13053-014-0022-x","volume":"13","author":"AR Timoteo","year":"2015","unstructured":"Timoteo AR, Albuquerque BM, Moura PC, Ramos CC, Agnez-Lima LF, Walsh T, King MC, Lajus TB. Identification of a new BRCA2 large genomic deletion associated with high risk male breast cancer. Hered Cancer Clin Pract. 2015;13:2.","journal-title":"Hered Cancer Clin Pract."},{"key":"288_CR22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1399-0004.2007.00773.x","volume":"71","author":"YK Lim","year":"2007","unstructured":"Lim YK, Lau PT, Ali AB, Lee SC, Wong JE, Putti TC, Sng JH. Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer. Clin Genet. 2007;71:331\u201342.","journal-title":"Clin Genet"},{"key":"288_CR23","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.295.12.1379","volume":"295","author":"T Walsh","year":"2006","unstructured":"Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, Roach KC, Mandell J, Lee MK, Ciernikova S, Foretova L, Soucek P, King MC. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA. 2006;295:1379\u201388.","journal-title":"JAMA"},{"key":"288_CR24","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1136\/jmg.2005.032789","volume":"42","author":"S Agata","year":"2005","unstructured":"Agata S, Dalla Palma M, Callegaro M, Scaini MC, Menin C, Ghiotto C, Nicoletto O, Zavagno G, Chieco-Bianchi L, D\u2019Andrea E, Montagna M. Large genomic deletions inactivate the BRCA2 gene in breast cancer families. J Med Genet. 2005;42:e64.","journal-title":"J Med Genet"},{"key":"288_CR25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10549-007-9499-6","volume":"106","author":"A Buffone","year":"2007","unstructured":"Buffone A, Capalbo C, Ricevuto E, Sidoni T, Ottini L, Falchetti M, Cortesi E, Marchetti P, Scambia G, Tomao S, Rinaldi C, Zani M, Ferraro S, Frati L, Screpanti I, Gulino A, Giannini G. Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and\/or ovarian cancer families. Breast Cancer Res Treat. 2007;106:289\u201396.","journal-title":"Breast Cancer Res Treat"},{"key":"288_CR26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrg2593","volume":"10","author":"PJ Hastings","year":"2009","unstructured":"Hastings PJ, Lupski JR, Rosenberg SM, Ira G. Mechanisms of change in gene copy number. Nat Rev Genet. 2009;10:551\u201364.","journal-title":"Nat Rev Genet"},{"key":"288_CR27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10549-008-0088-0","volume":"115","author":"TV Hansen","year":"2009","unstructured":"Hansen TV, J\u00f8nson L, Albrechtsen A, Andersen MK, Ejlertsen B, Nielsen FC. Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families. Breast Cancer Res Treat. 2009;115:315\u201323.","journal-title":"Breast Cancer Res Treat."},{"key":"288_CR28","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1136\/jmg.2004.027961","volume":"42","author":"AM Woodward","year":"2005","unstructured":"Woodward AM, Davis TA, Silva AG, Kirk JA, Leary JA, kConFab Investigators. Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast\/ovarian cancer phenotype in selected families. J Med Genet. 2005;42:e31.","journal-title":"J Med Genet"},{"key":"288_CR29","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.1158\/0008-5472.CAN-04-2467","volume":"64","author":"I Tournier","year":"2004","unstructured":"Tournier I, Paillerets BB, Sobol H, Stoppa-Lyonnet D, Lidereau R, Barrois M, Mazoyer S, Coulet F, Hardouin A, Chompret A, Lortholary A, Chappuis P, Bourdon V, Bonadona V, Maugard C, Gilbert B, Nogues C, Fr\u00e9bourg T, Tosi M. Significant contribution of germline BRCA2 rearrangements in male breast cancer families. Cancer Res. 2004;64:8143\u20137.","journal-title":"Cancer Res"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40291-017-0288-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-017-0288-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-017-0288-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T05:32:55Z","timestamp":1505885575000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40291-017-0288-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,15]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["288"],"URL":"https:\/\/doi.org\/10.1007\/s40291-017-0288-6","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"type":"print","value":"1177-1062"},{"type":"electronic","value":"1179-2000"}],"subject":[],"published":{"date-parts":[[2017,6,15]]}}}